2 weeks Ago By ABMN Staff
Embecta Corp. ( NASDAQ:EMBC – Get Free Report ) was the target of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 1,960,000 shares, a growth of 6.
5% from the August 31st total of 1,840,000 shares. Based on an average daily volume of 420,000 shares, the short-interest ratio is currently 4.7 days.
Approximately 3.6% of the shares of the company are sold short. Hedge Funds Weigh In On Embecta Hedge funds have recently made changes to their positions in the business.
Iat Reinsurance Co. LTD. bought a new position in shares of Embecta in the second quarter worth about $50,000.
YHB Investment Advisors Inc. bought a new position in shares of Embecta in the first quarter worth about $56,000. CWM LLC boosted its stake in shares of Embecta by 773.
8% in the second quarter. CWM LLC now owns 9,079 shares of the company’s stock worth $113,000 after acquiring an additional 8,040 shares during the period. Cardinal Capital Management bought a new position in shares of Embecta in the first quarter worth about $134,000.
Finally, Canada Pension Plan Investment Board bought a new position in shares of Embecta in the second quarter worth about $140,000. Institutional investors own 93.83% of the company’s stock.
Embecta Stock Up 0.1 % NASDAQ:EMBC traded up $0.01 during mid-day trading on Tuesday, hitting $14.
11. 323,453 shares of the company traded hands, compared to its average volume of 422,694. The stock’s fifty day moving average price is $15.
14 and its 200-day moving average price is $13.32. Embecta has a one year low of $9.
93 and a one year high of $19.79. The firm has a market cap of $813.
72 million, a price-to-earnings ratio of 11.74 and a beta of 1.00.
Embecta Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Tuesday, August 27th were paid a $0.15 dividend.
This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.25%.
The ex-dividend date was Tuesday, August 27th. Embecta’s dividend payout ratio (DPR) is 49.59%.
Analysts Set New Price Targets Separately, Morgan Stanley cut their price target on Embecta from $13.00 to $12.00 and set an “underweight” rating for the company in a report on Monday, July 15th.
Read Our Latest Stock Analysis on Embecta About Embecta ( Get Free Report ) Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Read More Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter ..
